rss
Br J Ophthalmol 2008;92:717-718 doi:10.1136/bjo.2008.139378
  • Letter
    • PostScript

Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy

  1. Yoshinori Mitamura,
  2. Kazuha Ogata,
  3. Toshiyuki Oshitari,
  4. Noriko Asaumi,
  5. Shuichi Yamamoto
  1. Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan
  1. Y Mitamura, Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, 1–8–1 Inohana, Chuo-ku, Chiba 260–8670, Japan; ymita{at}faculty.chiba-u.jp
  • Accepted 15 February 2008

We read with interest the article by Arevalo et al1 about the development of a tractional retinal detachment (TRD) following the use of intravitreal bevacizumab (Avastin; Genetech Inc., San Francisco, California, USA) as an adjuvant to vitrectomy for the management of severe proliferative diabetic retinopathy (PDR). They warned that TRD might occur or progress shortly after intravitreal bevacizumab. We present a case of a retinal detachment with macular hole (MH–RD) that developed after intravitreal bevacizumab that was used for neovascular glaucoma as a result of severe PDR.

CASE REPORT

A 40-year-old man with diabetes of 19 years presented with PDR and neovascular glaucoma in the right eye that was refractory to panretinal photocoagulation (PRP). He was being treated with insulin but had …

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.